Key Financial Data Of Reporting Company

KYORIN Pharmaceutical Co., Ltd. - Filing #7582701

Concept 2022-07-01 to
2022-09-30
As at
2022-09-30
2022-04-01 to
2022-09-30
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-09-30
2021-07-01 to
2021-09-30
2021-04-01 to
2021-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
49,093,000,000 JPY
105,534,000,000 JPY
49,102,000,000 JPY
Ordinary profit (loss)
1,171,000,000 JPY
5,569,000,000 JPY
285,000,000 JPY
Net assets
124,735,000,000 JPY
124,507,000,000 JPY
121,927,000,000 JPY
Total assets
175,461,000,000 JPY
171,924,000,000 JPY
164,408,000,000 JPY
Basic earnings (loss) per share
1.04
21.69
68.62
10.19
2.12
Diluted earnings per share
Equity-to-asset ratio
0.711 xbrli:pure
0.724 xbrli:pure
0.742 xbrli:pure
Net cash provided by (used in) operating activities
6,218,000,000 JPY
6,346,000,000 JPY
9,432,000,000 JPY
Net cash provided by (used in) investing activities
-3,707,000,000 JPY
-2,560,000,000 JPY
-1,907,000,000 JPY
Net cash provided by (used in) financing activities
-2,030,000,000 JPY
-4,112,000,000 JPY
-2,776,000,000 JPY
Cash and cash equivalents
27,001,000,000 JPY
26,289,000,000 JPY
31,298,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.